Robert Citronberg, MD
Infectious Disease · Oak Lawn, ILNPI 1982655395
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $24,505 of the $28,841 with a category attached, or 85.0%. Pfizer accounts for 89.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $14,571 and has fallen 70.8% since, to $4,250 in 2024. Among infectious disease clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $873.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$26K
- Melinta Therapeutics, LLC$2K
- Shionogi Inc$795
- Tetraphase Pharmaceuticals, Inc.$155
- Covidien LP$143
- Astellas Pharma US Inc$29
- plus $40 from 2 others
What the payments were for
- Consulting fees$7953%
- Speaking & faculty fees$24,50585%
- Travel & lodging$2,4989%
- Food & beverage$1,0144%
- Education$290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 21 | $25,660 |
| Melinta Therapeutics, LLC | 4 | $2,019 |
| Shionogi Inc | 1 | $795 |
| Tetraphase Pharmaceuticals, Inc. | 3 | $155 |
| Covidien LP | 1 | $143 |
| Astellas Pharma US Inc | 1 | $29 |
| AbbVie | 1 | $24 |
| Merck | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PREVNAR 20$10,639
- PAXLOVID$5,631
- Vabomere$1,950
- PREVNAR - 13$1,525
- ABRYSVO$1,000
- Fetroja$795
- PENBRAYA$476
- Xerava$118
How this compares
$28,841 in reported general payments places this provider in the 90th percentile of 368 infectious disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Oak Lawn
- Frank PalellaChicago$987K
- Jeffrey ShermanDeerfield$527K
- Catherine CreticosChicago$335K
- Babafemi TaiwoChicago$292K
- Beverly ShaChicago$202K
- Chad ZawitzChicago$193K
- Nancy GlickChicago$186K
- Kamaljit SinghChicago$138K
- Jorge ParadaMaywood$128K
- James SullivanChicago$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.